Active Watch List: 3D Systems Corporation (NYSE:DDD), FactSet Research Systems (NYSE:FDS), Aspen Insurance Holdings Ltd. (NYSE:AHL), Simpson (NYSE:SSD), Prosensa (NASDAQ:RNA)

On August 12,2014 3D Systems (NYSE:DDD) announced that it has signed a lease on a new 200,000 square foot facility in Rock Hill, South Carolina, increasing its manufacturing and distribution capacity to meet growing demand for its 3D printers and materials. The addition of this new manufacturing and distribution center is part of the company’s previously announced expansion, which is expected to generate hundreds of new … Continue reading Active Watch List: 3D Systems Corporation (NYSE:DDD), FactSet Research Systems (NYSE:FDS), Aspen Insurance Holdings Ltd. (NYSE:AHL), Simpson (NYSE:SSD), Prosensa (NASDAQ:RNA)

Chris Lewis08/19

Active Stocks : Prosensa Holding (NASDAQ:RNA), Blucora (NASDAQ:BCOR), Foster Wheeler (NASDAQ:FWLT), Five Oaks Investment Corp. (NYSE:OAKS), AirMedia Group Inc. (NASDAQ:AMCN)

The Rosen Law Firm, P.A. reminds all purchasers of Prosensa Holding N.V. (NASDAQ:RNA) ordinary shares of the important September 16, 2014 lead plaintiff deadline in the class action. Prosensa Holding N.V. (NASDAQ:RNA) belongs to Healthcare sector. Its net profit margin is -27.60% and weekly performance is 1.46%. On last trading day company shares ended up $9.76. Prosensa Holding N.V. (NASDAQ:RNA) distance from 50-day simple moving … Continue reading Active Stocks : Prosensa Holding (NASDAQ:RNA), Blucora (NASDAQ:BCOR), Foster Wheeler (NASDAQ:FWLT), Five Oaks Investment Corp. (NYSE:OAKS), AirMedia Group Inc. (NASDAQ:AMCN)

Mark Doerr08/11

Biotech Stocks: Ultragenyx Pharmaceutical Inc (NASDAQ:RARE), Prosensa Holding NV (NASDAQ:RNA), Agios Pharmaceuticals Inc (NASDAQ:AGIO), Seattle Genetics, Inc. (NASDAQ:SGEN), Idera Pharmaceuticals Inc (NASDAQ:IDRA)

Ultragenyx Pharmaceutical Inc (NASDAQ:RARE) on July 9 announced the pricing of its underwritten public offering of 2,017,349 shares of its common stock at a price to the public of $40.00 per share, before underwriting discounts. Ultragenyx is selling 1,311,277 shares of its common stock in this offering, and certain selling stockholders are selling 706,072 shares of common stock in this offering. Ultragenyx Pharmaceutical Inc (NASDAQ:RARE) … Continue reading Biotech Stocks: Ultragenyx Pharmaceutical Inc (NASDAQ:RARE), Prosensa Holding NV (NASDAQ:RNA), Agios Pharmaceuticals Inc (NASDAQ:AGIO), Seattle Genetics, Inc. (NASDAQ:SGEN), Idera Pharmaceuticals Inc (NASDAQ:IDRA)

Adam Keintzel07/1007/10

Volatile Stocks: Prosensa Holding (NASDAQ:RNA), 22nd Century Group Inc (NYSEMKT:XXII), Alnylam Pharmaceuticals (NASDAQ:ALNY), AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO), ZIOPHARM Oncology Inc. (NASDAQ:ZIOP)

Prosensa Holding NV (NASDAQ:RNA) was upgraded by stock analysts at KBC Securities from a “hold” rating to an “accumulate” rating in a report issued on Wednesday. The firm currently has a $11.00 price objective on the stock, up from their previous price objective of $7.00. KBC Securities’ target price would indicate a potential upside of 1.57% from the company’s current price. Prosensa Holding NV (NASDAQ:RNA) … Continue reading Volatile Stocks: Prosensa Holding (NASDAQ:RNA), 22nd Century Group Inc (NYSEMKT:XXII), Alnylam Pharmaceuticals (NASDAQ:ALNY), AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO), ZIOPHARM Oncology Inc. (NASDAQ:ZIOP)

Colin Pettis06/10

Gilead Sciences GILD NASDAQ:GILD

Biotech Volatile Stocks: DARA Biosciences Inc (NASDAQ:DARA), Concert Pharmaceuticals Inc (NASDAQ:CNCE), Prosensa Holding NV (NASDAQ:RNA), CytRx Corporation (NASDAQ:CYTR)

DARA Biosciences Inc (NASDAQ:DARA) on May 15 announced its support for Neuropathy Awareness Week which is being observed during the week of May 12, 2014 and sponsored in the U.S. by The Neuropathy Association (www.neuropathy.org). DARA Biosciences Inc (NASDAQ:DARA) stock performance was -26.61% in last session and finished the day at $1.60. Traded volume was 4.15million shares in the last session and the average volume … Continue reading Biotech Volatile Stocks: DARA Biosciences Inc (NASDAQ:DARA), Concert Pharmaceuticals Inc (NASDAQ:CNCE), Prosensa Holding NV (NASDAQ:RNA), CytRx Corporation (NASDAQ:CYTR)

Kevin Long05/30

Biotech Losers: PTC Therapeutics (NASDAQ:PTCT), Prosensa Holding (NASDAQ:RNA), Concert Pharmaceuticals Inc (NASDAQ:CNCE), Tetralogic Pharmaceuticals Corp (NASDAQ:TLOG), Agios Pharmaceuticals Inc (NASDAQ:AGIO)

One solution, developed by PTC Therapeutics Inc. (NASDAQ:PTCT), a US biotechnology company, is to intervene in the transcription process in which the DNA is converted first to messenger RNA and then into protein. PTC Therapeutics Inc. (NASDAQ:PTCT)’s experimental drug ataluren is designed to override the false stop signal by interacting with the ribosome – the tiny biological machine inside every cell that runs along messenger … Continue reading Biotech Losers: PTC Therapeutics (NASDAQ:PTCT), Prosensa Holding (NASDAQ:RNA), Concert Pharmaceuticals Inc (NASDAQ:CNCE), Tetralogic Pharmaceuticals Corp (NASDAQ:TLOG), Agios Pharmaceuticals Inc (NASDAQ:AGIO)

Richard Atkins05/16